Spherical IOL provides a higher CDVA compared to aspheric lens

Article

Fitting a spherical acrylic intraocular lens (IOL) in patients with bilateral cataract improves corrected distance visual acuity (CDVA) more so than fitting an aspheric IOL.

Fitting a spherical acrylic intraocular lens (IOL) in patients with bilateral cataract improves corrected distance visual acuity (CDVA) more so than fitting an aspheric IOL, claims an investigation featured in Journal of Cataract and Refractive Surgery.

Dr Manickam Thiagarajan and his team, Eye Department, Southampton University Hospital, UK, conducted a randomized, masked, single-centre study on bilateral cataract patients aged 50 years and over. The biometry-predicted IOL power was between 10.0 D and 30.0 D. Patients were fitted with the Akreos Adapt Advanced Optics aspheric IOL and the Sensar AR40e spherical acrylic IOL.

A high-contrast logMAR chart was used to measure CDVA, the Pelli-Robson chart was used to measure contrast sensitivity, range of accommodation was measured using the RAF rule and patient satisfaction was recorded by questionnaire 3 months postoperatively. Pseudoaccommodation, mesopic pupil diameters and scotopic pupil diameters were all measured with a power refractor.

The difference in mean CDVA between the IOLs was 0.015, with the spherical IOL scoring the highest. The differences between contrast sensitivity and range of accommodation were 0.02 and 0.05, respectively. The questionnaire answers produced no differences in dysphotopsia and patient satisfaction.

The spherical IOL demonstrated a statistically significant improvement in CDVA but the findings are not clinically important.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
© 2025 MJH Life Sciences

All rights reserved.